Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹73 Cr
Revenue (TTM)
₹49 Cr
Net Profit (TTM)
₹6 Cr
ROE
55.2 %
ROCE
34.3 %
P/E Ratio
11.9
P/B Ratio
1.7
Industry P/E
34.04
EV/EBITDA
8.8
Div. Yield
0 %
Debt to Equity
1
Book Value
₹27.3
EPS
₹10.3
Face value
10
Shares outstanding
8,084,434
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Curis Lifesciences
| -25.4 | -8.2 | -28.3 | -- | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Curis Lifesciences
|
90.0 | 72.7 | 49.1 | 6.1 | -- | 55.2 | 11.9 | 1.7 |
| 352.7 | 3,213.2 | 2,521.8 | 202.5 | 9.6 | 14.3 | 15.9 | 2.1 | |
| 989.6 | 12,119.0 | 2,512.3 | 543.7 | 28.3 | 19.3 | 22.3 | 3.8 | |
| 357.4 | 6,190.1 | 1,053.1 | 293.6 | 32.3 | 24.6 | 21.1 | 4.8 | |
| 1,025.1 | 10,733.1 | 1,158.7 | 309.6 | 31.9 | 17.3 | 34.3 | 5.7 | |
| 1,547.6 | 29,354.2 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.7 | 5.9 | |
| 12,433.0 | 15,953.0 | 1,575.1 | 179.1 | 14.9 | 11.4 | 89.1 | 9.6 | |
| 784.3 | 3,617.1 | 588.5 | 102.9 | 22.1 | 12.7 | 35.6 | 4.3 | |
| 615.1 | 6,946.9 | 502.0 | 138.7 | -- | 32.8 | 50.1 | 8.0 | |
| 158.0 | 4,151.0 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 6.2 |
No Review & Analysis are available.
--
Incorporated
2016
Chairman
Dharmesh Dasharathbhai Patel
Managing Director
Dharmesh Dasharathbhai Patel
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Curis Lifesciences Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Curis Lifesciences Ltd is ₹89.95 (NSE) as of 02-Apr-2026 IST. Curis Lifesciences Ltd has given a return of --% in the last 1 years.
The P/E ratio of Curis Lifesciences Ltd is 11.91 times as on 02-Apr-2026, a 65 discount to its peers’ median range of 34.04 times.
The P/B ratio of Curis Lifesciences Ltd is 1.66 times as on 02-Apr-2026, a 59 discount to its peers’ median range of 4.05 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Curis Lifesciences Ltd are Rs 147.90 and Rs 83.60 as of 04-Apr-2026.
Curis Lifesciences Ltd has a market capitalisation of ₹ 73 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Curis Lifesciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-9.95
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.